Trading statement – Audited group results for the year ended 31 March 2013 MEDICLINIC INTERNATIONAL LIMITED (Incorporated in the Republic of South Africa) (Registration number: 1983/010725/06) (Share code: MDC) (ISIN: ZAE000074142) ("Mediclinic" or “the Company”) TRADING STATEMENT – AUDITED GROUP RESULTS FOR THE YEAR ENDED 31 MARCH 2013 In terms of the JSE Limited (“JSE”) Listings Requirements, companies are required to publish a trading statement as soon as they are satisfied that a reasonable degree of certainty exists that the financial results for the period to be reported upon next will differ by at least 20% from that of the previous corresponding reporting period. Mediclinic is in the process of finalising its year-end results for the twelve months ended 31 March 2013, which are due to be released on SENS on 22 May 2013 and published in the press on 23 May 2013 (“year-end results announcement”). Accordingly, shareholders are advised that the Company’s basic earnings per share (“EPS”) and basic headline earnings per share (“HEPS”) for the year ended 31 March 2013 are expected to be between 164% and 174% lower than that reported for the previous corresponding reporting period (“the EPS and HEPS range”). In order to provide clear and meaningful guidance to shareholders, this trading statement will also address normalised HEPS. Normalised HEPS are defined as reportable HEPS in terms of accounting standards, excluding one-off items. The one-off items are included in calculating the EPS and HEPS range and relate mainly to the refinancing charges as reported in the interim results on 6 November 2012. Details of one-off items will be provided in the year-end results announcement. Excluding the one-off items, the normalised HEPS for the year ended 31 March 2013 are expected to be between 37% and 47% higher than the normalised HEPS reported for the previous corresponding reporting period. The financial information on which this trading statement is based has not been reviewed and reported on by the Company’s external auditors. Stellenbosch 17 May 2013 Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa PO Box 456, Stellenbosch 7599, South Africa Tel +27 21 809 6500 Fax +27 21 886 4037 Ethics line: 0800 005 316 Website: www.mediclinic.com Sponsor RAND MERCHANT BANK (A division of FirstRand Bank Limited) Date: 17/05/2013 09:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.